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Background. Nephrotoxic glomerulonephritis is induced by
the administration of antibody against the glomerular basement
membrane (GBM). We demonstrated previously that Fc recep-
tors for immunoglobulin G (IgG) (FcR) play crucial roles in
the induction of accelerated nephrotoxic glomerulonephritis
by using FcR-deficient (/) mice. Since FcR/mice lack
the cell surface expression of two activating FcRs, FcRI
and FcRIII. The present study aims to identify the FcR
responsible for the induction of nephrotoxic glomerulonephritis.
Methods. Accelerated anti-GBM glomerulonephritis was in-
duced in FcRI/, FcRIII/, and FcR/ mice by pre-
immunization with rabbit IgG followed by inoculation of rabbit
anti-GBM antibody. Histologic analysis and immunostaining
of renal sections were performed.
Results. FcRI/ mice as well as wild-type mice showed
severe glomerulonephritis with hypernitremia by the adminis-
tration of anti-GBM antibody. In contrast, FcRIII/ mice
showed much milder renal involvement, similar to FcR/
mice. Histologically, FcRI/mice showed intracapillary pro-
liferation, glomerular thrombosis, and crescent formation,
whereas FcRIII/ mice showed only glomerular hypercellu-
lar changes. The depositions of anti-GBM antibodies, autologous
antibodies and complement C3 along the GBM were equally
observed among all three FcR/ mouse types by immuno-
staining.
Conclusions. Accelerated nephrotoxic glomerulonephritis is
induced predominantly through FcRIII but not FcRI.
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Immune complex–mediated inflammation is a common
mechanism of various autoimmune diseases such as sys-
temic lupus erythematosus, rheumatoid arthritis, vasculi-
tis, and glomerulonephritis, including Goodpasture’s syn-
drome. Deposition of autoantibodies and immune complex
to the systemic or specific organ triggers immune com-
plex–mediated inflammation and tissue injury. Immune
complex–induced diseases had been thought to be medi-
ated mainly by complement activation, which then re-
cruited various inflammatory cells. These cells then in-
duce the further inflammation cascade. However, recent
analyses of various Fc receptor (FcR)–deficient mice
have shown that FcR plays crucial roles in the induction
of immune complex–triggered inflammations [1–7].
FcRs play important roles in the connection between
humoral and cellular responses by linking the antigen-
specific interactions of antibodies to the nonspecific ef-
fector mechanisms of FcR-bearing cells [8–10]. In the
mouse system, there are three classes of Fc receptors
for immunoglobubulin G (IgG) (FcR), FcRs: FcRI
(CD64) is the high-affinity receptor able to bind to mono-
meric IgG (especially IgG2a), and the two low-affinity
receptors FcRII (CD32) and FcRIII (CD16), which
bind mainly to polymeric IgG and IgG within immune
complex. In addition, FcR can be divided functionally
into two groups: activating (FcRI and FcRIII) and
inhibitory (FcRII) receptors. The two activating recep-
tors, FcRI and FcRIII, are associated with the  chain
(FcR) homodimer. FcR functions as signal transducer
of IgG-binding signals and is also required for the cell
surface expression of both activating receptors. It has
been shown that FcR-deficient (/) mice do not ex-
press any functional activating FcR on the surface of
various cells [1, 11], although recent study on FcRI-
deficient mice showed reduced but not diminished sur-
face appearance of functional FcRI in FcR/ mice
[12]. Important functions of FcR have been demon-
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strated by showing that FcR/mice exhibited impair-
ment in immune complex–mediated Arthus reaction, a
representative type III hypersensitivity [13], and resistance
to experimental hemolytic anemia as well as thrombocy-
topenia, a representative type II inflammatory sensitivity
[2, 5]. Impaired Arthus reaction and low susceptibility
to IgG-induced hemolytic anemia have also been observed
in FcRIII/ mice [3, 14]. Recently, FcRI-deficient
mice were produced [12, 15], and showed some func-
tional impairments in IgG2a-immune complex–induced
phagocytosis and cytotoxity, as well as in antigen presen-
tation. In vivo, FcRI/ mice were partially protected
from IgG2a-induced autoimmune hemolytic anemia and
systemic anaphylaxis, suggesting that FcRI has its own
role, which FcRIII is unable to compensate for in vivo
[15]. The availability of these knockout mice of two acti-
vating FcRs, FcRI and FcRIII, has enabled us to dis-
sect and analyze the individual role in the FcR-depen-
dent inflammatory and autoimmune diseases.
Human Goodpasture’s syndrome is an autoimmune
disease with the characteristic rapidly progressive glomeru-
lonephritis and hemorrhagic pneumonitis. The presence
of autoantibodies on glomerular and alveolar basement
membranes and the deposition of the immune complex
along these basement membranes have been suggested
to be major pathogenic factors of the disease. For the
analysis of renal involvement in Goodpasture’s syndrome,
an experimental model of anti-gomerular membrane dis-
ease (GBM) glomerulonephritis, known as nephrotoxic
serum glomerulonephritis or Masugi nephritis, has been
used. This model is a representative type II inflammatory
hypersensitivity and is induced by injection of anti-GBM
antigens into rats, rabbits, or mice [16–20]. We have
demonstrated that the induction of the murine model of
accelerated anti-GBM glomerulonephritis was depen-
dent on FcR from the finding that anti-GBM glomerulo-
nephritis is not induced at all in FcR/ mice [11].
In this system, wild-type mice exhibited severe renal
damage, such as crescent formation and glomerular
thrombosis, whereas FcR/ mice were completely
protected from renal damage without any hypercellular-
ity in the glomeruli [11].
In the present study, we examined the individual con-
tributions of stimulatory FcRI and FcRIII using each
type of FcR-deficient mouse to clarify the mechanism
of the induction of accelerated Masugi nephritis by iden-
tification of the responsible FcR. We demonstrated that
FcRI/ mice induced a quite similar disease to that
of wild-type mice, whereas FcRIII/ mice exhibited
resistance to anti-GBM glomerulonephritis that was
rather similar to that of FcR/ mice. These results
indicate that FcRIII plays a predominant role in the
induction of anti-GBM glomerulonephritis.
METHODS
Mice
C57BL/6 mice were purchased from Shizuoka Labor-
atory Animal Corp. (Hamamatsu, Japan). The estab-
lishment and characteristics of FcR/ mice with
C57BL/6 background have been described previously
[11]. FcRI/ and FcRIII/ mice were produced
as described previously [3, 15] and backcrossed into
C57BL/6 for six and twelve generations, respectively.
All mice were bred and maintained in our own animal
facility under specific pathogen-free conditions. Experi-
ments were performed according to institutional guide-
lines. Ten- to 14-week age-matched female mice were
used in all experiments.
Preparation of rabbit antimouse GBM antiserum
Rabbit anti-GBM antigens was prepared as previously
described [11]. Briefly, glomeruli were obtained from
kidneys of C57BL/6 mice by sieving with No. 100 and
250 meshes and disrupting by supersonic vibration. The
cellular fraction was removed from glomeruli by centrifu-
gation three times at 2000g. The final precipitate was
digested by trypsin at 37C for 18 hours in 0.1 mol/L Tris
buffer (pH 8.2). After centrifugation, the supernatant
was collected and used as the “GBM antigen.” New
Zealand White rabbits were immunized with 10 mg of the
GBM antigen emulsified in complete Freund’s adjuvant
(CFA)(Wako, Osaka, Japan) in the back six times weekly
and finally intravenously with 2.5 mg of GBM antigen
alone. The sera obtained from the rabbits were mixed
and used as rabbit antimouse GBM antibodies.
Induction of accelerated Masugi nephritis
Nephrotoxic glomerulonephritis was induced as pre-
viously described [11]. Briefly, six female mice per group
were immunized intraperitoneally with 250 g of rabbit
IgG (Cappel, Aurora, Ohio, USA) in CFA, followed by
intravenous injection of 250 L of rabbit antimouse GBM
antibodies 4 days later. On days 7 and 14 after the injec-
tion, serum and urine samples were collected to evaluate
renal function. Thereafter, all mice were sacrificed for
the histologic assessment on day 14 after the anti-GBM
antibody injection. Moreover, to investigate infiltrating
cells in the initial phase of glomerulonephritis, three
female mice per group were sacrificed at 3 hours after
administration of anti-GBM antibodies, according to the
previous study of polymorphonuclear cell (PMN) re-
cruitment in anti-GBM nephritis [21–23].
Histologic analysis
Kidneys were removed, fixed in 10% buffered forma-
lin, and embedded in paraffin. Paraffin sections were
stained with hematoxylin and eosin (H&E) and periodic
acid-Schiff (PAS) and evaluated by light microscopy. All
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histologic analysis was performed in a blinded fashion.
We utilized a modified scoring system of experimental
glomerulonephritis described by Raji et al [24, 25] and
Kanamaru et al [26]; briefly, the following light micro-
scopic features were evaluated: (1) intracapillary cellular
proliferation; (2) glomerulosclerosis, defined as the dis-
appearance of cellular elements from the tuft, collapse
of the capillary lumen, and folding of the GBM with en-
trapment of amorphous material; (3) glomerular throm-
bosis; and (4) extracapillary cellular proliferation (cres-
cent). Morphologic changes for the first three criteria
were quantitated as a score of 1 to 4. A score of 1 was
equivalent to 25% of the glomeruli affected by the particu-
lar morphologic change, and 4 represented involvement
of 100% of the glomeruli. Intermediate values were as-
signed a value of 0.5. An injury score was then obtained
by multiplying the severity score by the percentage of
glomeruli exhibiting the same severity of the change. The
extent of injury for each individual tissue specimen was
then obtained by the addition of these distinct scores. Mor-
phologic change for the fourth criterion was expressed
directly as the percentage of glomeruli. Twenty equatori-
ally sectioned glomeruli per kidney were assessed.
Immunofluorescence and
immunohistochemical staining
The kidneys obtained at autopsy were rolled in Tissue
Tek 22-oxacalcitriol (OCT) (Miles, Inc., Elkhart, IN, USA)
compound, snap-frozen in liquid nitrogen, and stored at
80C. Frozen sections were cut at a thickness of 5 m
and fixed in acetone at 30C. For the immunofluores-
cence study, cryostat sections were stained with fluores-
cein isothiocyanate (FITC)-conjugated goat antirabbit
IgG, Cy3-conjugated antimouse IgG, and goat antimouse
C3. As for immunohistochemical study, the cryostat sec-
tions were quenched intrinsic peroxidase by H2O2 and
incubated with horseradish peroxidase (HRP)-conju-
gated rabbit antimouse IgG1 or IgG2a antibodies. For
visualization, 3-3-diaminobenzidine (DAB) was used as
substrate. For immunostaining of cell marker, those cryo-
stat sections were stained with biotinylated rat antimouse
neutrophil monoclonal antibodies (mAbs) (clone 7/4) for
PMN, biotinylated anti-B220 antibodies for B cells, and
biotinylated anti-Thy1.2 mAbs for T cells. Macrophages
were stained with goat antimouse CD68 antibodies fol-
lowed by biotinylated donkey antigoat IgG antibody.
The number of these infiltrating cells in glomeruli was
determined by counting cells in glomeruli (more than 50
per mouse) at each time point (at 3 hours and on day
14 after administration of anti-GBM antibody).
Hematologic examination and
measurement of albuminuria
Serum levels of blood urea nitrogen (BUN), creati-
nine, and albumin were measured by standard methods
for blood chemistry: urease glutamate dehydrogenase
(urease-GLDH) (Kyowa, Tokyo, Japan) for BUN, crea-
tinase-peroxidase (CRTNase-POD) (Kainos, Tokyo, Ja-
pan) for creatinine, and bromocresol green method for
albumin. Mouse urine was individually collected in a
metabolic cage for 12 hours on days 7 and 14 after admin-
istration of anti-GBM antibodies. Mice were allowed
free access to water but not food.
Measurement of specific antibodies in serum by
enzyme-linked immunosorbent assay (ELISA)
Serum levels of antirabbit IgG antibodies and the anti-
body against individual IgG subclasses (IgG1 or IgG2a)
were measured by ELISA. A 96-well microplate was
coated with 10 g/mL rabbit IgG (Sigma Chemical Co.,
St. Louis, MO, USA) in 0.1 mol/L NaHCO3 at 4C over-
night, blocked, and applied with 50 L/well of diluted
serum. After reaction at 37C for 1 hour, the wells were
washed 5 times with phosphate-buffered saline (PBS)
containing 0.05% Tween 20 (PBST) and incubated with
biotin-conjugated goat antimouse IgG-Fc (Sigma Chemi-
cal Co.) antibody at room temperature for 1 hour. After
washing with PBST, the plate was incubated with avidin-
peroxidase at room temperature for 30 minutes. For mea-
surement of the specific mouse IgG1 or IgG2a antibody,
palate was incubated with HRP-coupled antimouse IgG1
or IgG2a antibody at room temperature for 1 hour, fol-
lowed by washing and the addition of tetramethyl benzi-
dine (TMB) as a substrate. Optical density at 450 nm was
measured by an ELISA reader.
Statistics
Data are shown as mean  SD. Statistical differences
in each group for the level of albuminuria, blood chemis-
try, and pathologic score were calculated using the Mann-
Whitney U test. Counted numbers of the glomerular
infiltrating cells were assesed by Bonferroni/Dunn test.
Differences were considered significant when P  0.05.
RESULTS
To elucidate the individual roles of the two activating
FcRs (FcRI and FcRIII) in the induction of anti-
GBM glomerulonephritis, accelerated anti-GBM glo-
merulonephritis was induced in wild-type, FcRI/,
FcRIII/, and FcR/ mice, all with C57BL/6
background or backcrossed to C57BL/6 for at least six
generations. The mice were preimmunized with rabbit
IgG and then injected with rabbit anti-GBM antibodies
4 days later, and were analyzed on days 7 and 14 after
anti-GBM antibody injection. The differences between
several clinical and pathologic alterations were com-
pared among these mice.
Serologic examination of FcR/ mice
Serum markers of renal damage were evaluated on
days 7 and 14. BUN values were increased on days 7
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and 14 in FcRI/ mice (111.1  82.8 mg/dL, 219.0 
138 mg/dL, respectively) in a manner similar to wild-
type mice (105.2 42.2 mg/dL, 131.3 64.6 mg/dL, respec-
tively). On the other hand, BUN values in FcRIII/
mice (31.1 7.0 mg/dL, 40.3 17.2 mg/dL, respectively)
were almost the same as those in FcR/ mice (29.5 
8.0 mg/dL, 28.8  6.6 mg/dL), significantly lower than
those of wild-type and FcRI/ mice, and they stayed
within normal range or just around the upper limit (Fig.
1A). Much like the BUN values, those of serum creatinine
(Fig. 1B) and total cholesterol (Fig. 1D) of wild-type and
FcRI/ mice were similarly elevated and were signifi-
cantly higher than those of FcRIII/ and FcR/
mice. In stark contrast these increases upon anti-GBM
antibody injection, the serum albumin levels decreased
significantly in nephritic wild-type and FcRI/ mice
to a similar degree, whereas those of FcRIII/ and
FcR/ mice were not significantly reduced (Fig. 1C).
These results indicate that renal impairment was induced
in FcRI/ mice similarly to wild-type mice, while
FcRIII/ mice were resistant in a manner similar to
FcR/ mice.
Albuminuria in FcR/ mice
We then measured albuminuria on days 7 and day 14
following the disease induction to analyze the correlation
with renal impairment (Fig. 2). In wild-type mice, mas-
sive urinary albumin excretion was induced as compared
to FcR/mice [wild-type vs. FcR/mice (mg/day),
10.9  4.5 vs. 3.4  3.1 on day 7, and 8.9  3.5 vs. 3.2 
2.8 on day 14]. In FcRIII/ mice, urinary albumin
excretion was somewhat less than in wild-type on day 7,
although this difference became insignificant by day 14
(FcRIII/ vs. wild-type mice, 3.8  5.1 vs. 10.9  4.5
on day 7, 5.1  6.9 vs. 8.9  3.5 on day 14). In contrast,
urinary albumin excretion in FcRI/mice was similar
to that of wild-type mice (FcRI/ vs. wild-type mice,
7.1  2.4 vs. 10.9  4.5 on day 7, 9.3  1.8 vs. 8.9  3.5
on day 14). These results showed that albuminuria is
correlated with the serum markers in these FcR/
mice—FcRI/ and wild-type mice showed severe im-
pairment while FcRIII/ mice showed very mild al-
teration, similar to FcR/ mice, suggesting that albu-
minuria reflects the renal injury in this disease model.
Histologic alterations in FcR/ mice
We analyzed histologic severity of renal damage in an
effort to comfirm that the blood chemistry and protein-
uria results really reflect the renal damage. Paraffin-embed-
ded kidney sections of FcR/ mice were stained with
PAS. Wild-type and FcRI/ mice showed severe re-
nal damage with mesangial proliferation, inflammatory
cell infiltration, glomerular thrombosis, and crescent for-
mation in the glomeruli on day 14 after anti-GBM anti-
body injection. In contrast, FcR/ and FcRIII/
Fig. 1. Blood chemistry of mice injected with anti-glomerular basement
membrane (GBM) antibodies. Serum samples were collected from indi-
vidual mice on days 7 and 14 after anti-GBM antibody administration.
Serum levels of blood urea nitrogen (BUN) (A), creatinine (B), albumin
(C), and total cholesterol (D) were measured as described in the Meth-
ods section. Data are presented as mean  SD of six mice in each
group. Symbols are: wild-type (); FcRI/( ); FcRIII/();
FcR/( ); and negative control ( ) which are mice received rabbit
immunoglobulin G (IgG) immunization but no anti-GBM injection.
*P  0.05; **P  0.01.
mice were protected from severe glomerulonephritis,
and FcRIII/ mice showed only mesangial prolifera-
tion and cell infiltration (Fig. 3A). The severity of glo-
merulonephritis was graded in reference to these four
parameters: (1) intracapillary cellular proliferation, (2)
glomerular sclerosis, (3) glomerular thrombosis, and (4)
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Fig. 2. Albuminuria induced by anti-glomerular basement membrane
(GBM) antibody administration. Urine samples were collected from
individual mice (N  six female) in a metabolic cage on days 7 and 14
after anti-GBM antibody administration, and the amount of albumin-
uria was measured. The numbers indicate mean SD (mg/day). Abbre-
viations are: WT, wild-type; NC, negative control, mice receiving rabbit
immunoglobulin G (IgG) immunization but no injection of anti-GBM
antibodies. *P  0.05.
crescent formation as 0 to 4 for each according to modi-
fied criteria by Raji et al [24, 25] and Kanamaru et al
[26]. As shown in Figure 3B, the histologic score revealed
that FcRI/mice developed severe glomerulonephri-
tis as well as wild-type mice, whereas FcRIII/ mice
showed much milder glomerulonephritis. However, it is
noteworthy that FcRIII/ mice still showed more
changes in glomerular, particularly intracapillary, prolif-
eration compared with FcR/ mice (Fig. 3B). From
these results, it can be concluded that the severity of
histologic renal damage corresponded to the level of
BUN and serum creatinine values. These findings dem-
onstrate that FcRIII plays a dominant role in the induc-
tion of accelerated anti-GBM glomerulonephritis and
also that FcRI may play some additional role, as
FcRIII/ mice exhibited a minor degree of impair-
ment when compared with FcR/ mice.
Antibody production in FcR/ mice after rabbit
IgG immunization
In order to determine the reason for the significant
differences in glomerulonephritis inducibility between
FcRI/ and FcRIII/ mice, we first measured the
production of anti-rabbit IgG antibodies in each mouse
by immunization with normal rabbit IgG to investigate
whether the mouse groups produce similar antibody re-
sponses required for the disease induction. The serum
titer of antirabbit IgG antibody in the individual mice
was measured by ELISA. All mouse groups except
FcR/ mice exhibited similar levels of the antibody
response against rabbit IgG, suggesting that FcRI/
and FcRIII/mice can produce normal levels of anti-
rabbit Ig antibody (Fig. 4) and the antibody production
does not explain the difference of the inducibility be-
tween these two mice. In FcR/ mice, the kinetics
of antirabbit IgG formation were delayed as compared
with wild-type, FcRI/, and FcRIII/ mice. The
antibody level in FcR/ mice was significantly lower
at the early phase (day 7) after anti-GBM antibody injec-
tion (data not shown), but the titer then increased on
day 14, although not to the level of the other mouse
groups (Fig. 4). However, as described below, the
amount of antibody may be sufficient to bind to anti-
GBM antibody in the kidney.
Local deposition of anti-GBM and
autologous antibodies
The renal sections of each experimental group were
stained with FITC-conjugated antirabbit IgG antibody
for anti-GBM antibody to exclude the possibility that
the resistance of FcR/ and FcRIII/ mice to
glomerulonephritis was caused by insufficient binding of
rabbit antimouse GBM antibodies to the GBM (Fig. 5).
The renal sections in all experimental groups were
stained with FITC-antirabbit IgG antibodies almost
equally along the GBM in a linear fashion after the
injection of antimouse GBM antibody. This proves that
the resistance of FcRIII/ and Fc R/ mice to
glomerulonephritis cannot be attributed to the failure of
the binding of anti-GBM antibody to the GBM. Further-
more, to detect the deposition of mouse antirabbit IgG
antibody against rabbit IgG that had been bound to
the GBM in the autologous phase, renal sections were
stained with Cy3-conjugated antimouse IgG antibody
(Fig. 6). As described above, the serum level of antirabbit
IgG antibody was lower in FcR/ mice than in the
other groups, but the deposition of mouse antirabbit
IgG antibody in renal tissue was similarly observed. The
difference of autologous antibody deposition in the renal
tissue of FcR/ mice was much less than expected
in the view of the serum level. Therefore, the titer differ-
ence of anti-GBM antibody does not appear to be the
reason for the failure of glomerulonephritis development
in FcR/ mice.
FcRI and FcRIII have different affinities for differ-
ent IgG subclasses, which comprise immune complexes.
Particularly, FcRI interacts preferentially with IgG2a-
containing immune complex, while FcRIII prefers to
interact with IgG1 immune complex. Therefore, we inves-
tigated such subclasses of autologous antibodies. In im-
munohistochemical staining of renal sections, both IgG1
and IgG2a autologous antibodies against rabbit anti-
GBM antibody were equally deposited along the GBM,
and we could not find a preference of deposition among
the experimental groups (Fig. 7).
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Fig. 3. Histopathologic alterations of kidneys
of FcR/ mice by anti-glomerular base-
ment membrane (GBM) antibody injection.
(A ) Light microscopic appearance of the renal
tissue stained with periodic-acid Schiff (PAS).
Histopathlogic examination of kidneys in
wild-type (A), FcRI/ (B ), FcRIII/
(C ), FcR/ (D ) mice on day 14 after anti-
GBM antibody injection or without injection
of anti-GBM antibody (E ), negative control.
Wild-type (A) and FcRI/ (B) mice
showed marked tissue damage such as intra-
capillary cellular proliferation, glomerular
thrombosis, and crescent formation. In con-
trast, FcRIII/ mice (C) exhibited mainly
hypercellular changes and were prevented
from severe glomerulonephritis. FcR/
mice (D) appeared almost normal. (B) Scoring
of renal histology for intracapillary cellular
proliferation (A), glomerular thrombosis (B),
glomerular sclerosis (C), and crescent forma-
tion (D), at day 14 after anti-GBM antibody
injection. The scoring protocol is described in
the Methods section. Data are represented as
mean  SD for six mice in each group. Sym-
bols are: wild-type (); FcRI/( );
FcRIII/(); FcR/( ); and negative
control ( ). **P  0.01.
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Fig. 4. Production of antirabbit immunoglobulin (Ig) antibody upon
immunization with rabbit IgG. Serum titer of antirabbit IgG antibody
in individual mice was measured by enzyme-linked immunosorbent
assay (ELISA). On day 14 after rabbit IgG immunization, serum levels
of anti-rabbit IgG antibody were almost the same among wild-type (),
FcRI/ () and FcRIII/ () mice, except for a little lower
level in FcR/ mice ().
Fig. 5. Deposition of rabbit antimouse glomerular basement mem-
brane (GBM) antibody along the GBM. Immunofluorescence staining
of the kidney in wild-type (A), FcRI/ (B), FcRIII/ (C), and
FcR/ (D) mice on day 14 after anti-GBM antibody injection. The
renal sections from these mouse groups were equally stained with fluo-
rescein isothiocyanate (FITC)-conjugated antirabbit immunoglobulin
G (IgG) in a linear pattern (	200 magnification).
Fig. 6. Deposition of autologous mouse antirabbit immunoglobulin
(Ig) antibody along the glomerular basement membrane (GBM). Immu-
nofluorescence staining of the kidney in wild-type (A), FcRI/ (B),
FcRIII/ (C), and FcR/ (D) mice on day 14 after anti-GBM
antibody injection. The renal sections from these mouse groups were
equally stained with Cy3-conjugated antimouse IgG antibody (	200
magnification).
Deposition of C3 on GBM in FcR/ mice
In addition, we investigated whether there was any dif-
ference in the binding of complement components in renal
tissue among the experimental groups after injection of
anti-GBM antibody to clarify the contribution of comple-
ments to the induction of the disease. Renal sections were
stained with FITC-conjugated antimouse C3 (Fig. 8). The
results showed that the C3 staining was equally observed
on the GBM in the sections in a linear fashion in all the
mouse groups. It was demonstrated that the deposition
of complement C3 was equally deposited regardless of
the mouse type, and C3 binding is not responsible for
the inflammatory cascade leading to renal injury.
Characterization of glomerular infiltrating cells
To identify the type of inflammatory cells involved
in the induction of glomerulonephritis, we performed
immunohistochemical staining of infiltrating/recruited
cells in glomeruli at 3 hours (initial phase) and day 14
(late phase) after administration of anti-GBM antibody
(Table 1). Whereas PMN were recruited into glomeruli
at the initial phase of glomerulonephritis in wild-type and
FcRI/ mice, the PMN recruitment was minimally
observed in FcRIII/ mice. The recruitment of other
cells, such as macrophage/monocytes, T cells and B cells,
was not remarkable. At the late phase of glomerulo-
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Fig. 7. Immunohistochemical staining for immunoglobulin (Ig) G1 and
IgG2a antibodies on renal tissues in all FcR/ mouse groups. The
kidneys in wild-type (A and E ), FcRI/ (B and F ), FcRIII/
(C and G ) and FcR/ (D and H ) mice on day 14 after anti-GBM
antibody administration were stained with antimouse IgG1 Ab (A to
D), or anti-mouse IgG2a antibody (E to H). Both antimouse IgG1 and
IgG2a antibodies in the glomeruli were equally stained in each group
(	200 magnification).
nephritis, the number of those inflammatory cells, includ-
ing PMN and macrophages, in the glomeruli was not dif-
ferent among the experimental groups. The difference in
the initial infiltration of FcR-bearing PMN/macrophages
is involved in the differential induction of glomerulo-
nephritis between FcRIII- and FcRI-deficient mice.
Fig. 8. Deposition of complement C3 along the glomerular basement
membrane (GBM). Immunofluorescence staining of the kidney in wild-
type (A), FcRI/ (B), FcRIII/ (C ), and FcR/ (D) mice
on day 14 after anti-GBM antibody injection. The renal sections from
these mice were stained equally with fluorescein isothiocyanate (FITC)-
conjugated antimouse C3 antibody (	200 magnification).
DISCUSSION
By establishing and analyzing FcR/mice, we dem-
onstrated in the previous study that the activating FcRs,
FcRI and/or FcRIII, play a crucial role in the induction
of accelerated nephrotoxic glomerulonephritis. The pres-
ent study advanced the analysis a step further in the identi-
fication of the responsible FcR, revealing that the induc-
tion of this model of glomerulonephritis is mediated
largely through FcRIII from the finding that FcRI/
mice showed severe renal damage at a similar level to
wild-type mice, whereas FcRIII/mice showed much
milder changes compared with wild-type and FcRI/
mice.
FcRI and FcRIII are both activating FcRs associ-
ated with a homodimer of the  subunit, but their affinities
for different subclasses of Ig and immune complex are
different [27]. As for the binding capacity to immune com-
plex, FcRI preferentially interacts with IgG2a-containing
immune complex, but not IgG1 immune complex [28].
In contrast, FcRIII can interact with IgG1 immune com-
plex in addition to IgG2a. Contribution of either of the
activating FcRs, FcRI or FcRIII, to the induction of
diseases appears to vary depending on the disease model.
In a serum-induced passive arthritis model (KRN model),
it has been shown that anti-glysoxyl-phosphatidylinositol
(GPI) antibodies induce the disease and FcRIII is the
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Table 1. Various cells infiltration into the glomeruli in anti-glomerular basement membrane (GBM) glomerulonephritis
Wild-type FcRI/ FcRIII/ FcR/ NC
Initial phase (3 hours)
PMN 1.870.24a,b 1.820.09a,b 0.610.08 0.450.11 0.380.05
M/Mo 0.370.05 0.310.01 0.280.06 0.240.10 0.150.02
T cell 0.050.01 0.070.04 0.060.01 0.060.03 0.040.01
B cell 0.120.06 0.120.06 0.080.06 0.140.07 0.130.07
Late phase (14 days)
PMN 0.790.15 0.830.12 0.530.16 0.590.14 0.050.01
M/Mo 1.750.09 1.640.22 1.610.33 1.640.07 0.130.09
T cell 0.150.06 0.100.01 0.130.04 0.130.09 0.050.02
B cell 0.150.02 0.140.04 0.170.05 0.160.07 0.040.01
Various glomerular infiltrating cell counts in wild-type, FcRI/, FcRIII/, FcR/ and NC mice. Cells were counted at 3 hours and 14 days after
administration of anti-GBM antibody. Data are expressed at the mean  SD per glomeular cross-section. Abbreviations are: M/Mo, macrophage/monocyte; PMN,
polymorphism cells.
aP  0.01 vs. FcRIII/ mice
bP  0.01 vs. FcR/ mice
dominant effector FcR for the induction probably through
activation of neutrophils and mast cells. FcRIII may
preferentially function on these cells because IgG1 appears
to be dominated among anti-GPI antibodies [29, 30].
Similarly, FcRIII plays an essential role in the induction
of a collagen-induced arthritis model [31]. In contrast,
even in a model for arthritis, it has been reported that
FcRI play a prominent role in inducing antigen-induced
arthritis [32].
In our actively induced nephrotoxic glomerulonephri-
tis model, FcRIII plays a critical role in disease induc-
tion. It is possible that qualitative and/or quantitative
differences in immune depositions in glomeruli between
FcRI/ and FcRIII/mice may influence the sus-
ceptibility for anti-GBM glomerulonephritis. However,
we failed to detect any apparent difference in the amount
of autologous antibodies (mouse antirabbit IgG anti-
body) bound to the heterologous antibody (rabbit anti-
mouse GBM antibody) that had been deposited onto the
GBM. Immunohistochemically, IgG1 and IgG2a antibod-
ies against anti-GBM antibody were equally deposited
along the GBM among the experimental groups. In addi-
tion, the degree of complement C3 deposition in the
glomeruli of FcRI/ and FcRIII/mice was similar
to that of wild-type mice. From these results, the differen-
tial sensitivity between FcRI/ and FcRIII/mice
in the induction of glomerulonephritis may not be attrib-
utable to the differential binding of different subclasses
of anti-GBM IgG antibodies. However, since the compo-
sition of IgG subclasses of anti-GBM antibody within the
immune deposits was hardly determined, we cannot ex-
clude the possibility that the characteristics of the immune
deposits containing different IgG subclasses in local re-
gions of glomeruli as well as kinetics of the binding are
associated with differential susceptibility to anti-GBM
glomerulonephritis between FcRI/ and FcRIII/
mice.
Another possibility is that the differential suscepti-
bility for glomerulonephritis between FcRI/ and
FcRIII/ mice may be due to the differences in the
FcR-bearing effector cells in the glomeruli in these
mice, and they are responsible for inducing glomerulo-
nephritis. Immune complex–mediated disease may result
from the activation of residential tissue inflammatory
cells and/or the recruitment of circulating monocytes or
neutrophils to the sites of immune complex deposition.
In the skin, resident FcR-bearing mast cells are necessary
for initiation of immune complex–triggered Arthus reac-
tion or vasculitis [4, 6, 33], whereas FcR-bearing alveolar
macrophages are likely to initiate the inflammatory re-
sponse of immune complex–mediated alveolitis in the
lung [7, 34]. In the kidney, it has been shown that bone
marrow–derived cells are required for anti-GBM glo-
merulonephritis by bone marrow transfer experiments
[35], and neutrophils and macrophage have been thought
to have a potency to induce immune complex–mediated
glomerulonephritis.
In the classical model of anti-GBM glomerulonephritis
[16, 18–21], heterologous anti-GBM antibody induces
glomerular damage through initial binding to the GBM,
followed by activation of complements with PMN infil-
tration into the glomeruli at the early heterologous phase.
Deposition of fibrin and necrosis of the glomerular capil-
laries were observed in severe cases [36]. There are sev-
eral bodies of evidence to support the idea that neutro-
phils play a critical role in the progression of renal injury.
First, neutrophil-depleted mice or beige mice lacking
neutrophil-neutral proteinase activity are protected from
glomerular injury [21, 37, 38]. Second, it has been sug-
gested that the recruitment of glomerular neutrophils is
mediated through FcR [21]. Third, the PMN influx both
at early and late phases of renal damage was minimal in
FcR/ mice [11, 22], and the accumulation of glomer-
uler neutrophils was reduced in FcRIII/ and
FcR/ mice [23, 39]. Consistent with these prevous
studies, our present study demonstrates that the PMN
recruitment was significantly suppressed in FcRIII/
mice as compared with wild-type mice and FcRI/
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mice (Table 1). Taken together with the fact that FcRI
is not expressed on neutrophils in the murine system [15],
it is likely that FcRIII on glomerular neutrophils may
play an important role in the recoginition of anti-GBM
antibody on glomeruli and the induction of accelerated
nephrotoxic glomerulonephritis.
Macrophages have also been thought to be important
effector cells in glomerulonephritis [40]. In the rat model
of anti-GBM glomerulonephritis, macrophage accumu-
lation is related to renal injury [41, 42]. However, in
mouse model of accelerated Masugi nephritis, our obser-
vation in Table 1 revealed that the infiltration of macro-
phages into the glomeruli was not remarkable at the
acute phase. In contrast, macrophage accumulation was
observed also in FcR/ mice at the late phase, sug-
gesting that this accumulation is FcR-independent [22].
Macrophages express both FcRI and FcRIII on the
surface, and produce proinflammatory cytokine such as
interleukin 1 (IL-1) and tumor necrois factor-
 (TNF-
)
and various chemokines upon the interaction of these
FcRs with immune complex. Since FcRI is occupied by
monomeric IgG2a in vivo, newly formed IgG2a-con-
taining immune complex can hardly access FcRI [43],
and only a high titer of specific IgG2a antibody can
occupy FcRI permanently [15, 44]. Since FcRIII plays
an essential role in anti-GBM glomerulonephritis as
demonstrated in the present study, the pathogenic effect
of macrophages, if there is a contribution, may be also
be induced mainly through FcRIII.
In addition to the obvious requirement of bone mar-
row–derived PMN and macrophage, it might be still possi-
ble that intrinsic renal cells, especially activated mesangial
cells, are involved in the induction of glomerulonephritis
because they also express FcRs [45] and mesangial cells
produce proinflammatory cytokine through FcR [46, 47].
It has been reported that the administration of anti-GBM
antibody induced the expression of FcR, particularly
FcRIII, in mesangial cells at the initial phase of glomer-
ulonephritis, which is required for neutrophil recruit-
ment and the production of chemokines such as mono-
cyte chemoattractant protein-1 (MCP-1) from these cells.
Together with the observation that in vitro stimulation
of mesangial cells by immune complex induces MCP-1
secretion through FcRIII [48], FcRIII activation by resi-
dent kidney cells might be involved in the disease.
In our anti-GBM glomerulonephritis model, FcRIII/
mice were similarly resistant to FcR/ mice in terms
of the induction of glomerulonephritis. However, it has to
be stressed that the former were not completely prevented
from renal injury when compared with the latter. This
renal damage includes intracapillary proliferation and
intravascular thrombosis. This observation in FcRIII/
mice may be attributed to the involvement of either
FcRI or an unknown receptor other than FcRI and
FcεRI, which is assembled with the  homodimer. Since
interferon- (IFN-) enhances the expression of FcRI,
increased contribution of Th1 cells and macrophages in
the disease model might promote the contribution of
FcRI. The greater contribution of macrophages over
neutrophils may be correlated with the involvement of
FcRI in any disease model. We are now generating
FcRI/RIII double-deficient mice with the same back-
ground, which should provide a clear answer to this ques-
tion. In addition, we are trying to identify the cells actu-
ally responsible for the induction of glomerulonephritis
by cell transfer experiments.
As shown in this study, identification of the responsible
FcR by the use of various combinations of FcR-defi-
cient mice and responsible FcR-bearing effector cells
by cell transfer into such knockout mice will unveil com-
plicated immune complex–mediated diseases, including
nephrotoxic glomerulonephritis.
ACKNOWLEDGMENTS
We thank Dr. K. Takase for discussion, Dr. S.-M. Chen for antibody
preparation, Ms. M. Sakuma and Ms R. Shiina for technical assistance,
and Ms. H. Yamaguchi and Ms Y. Kurihara for secretarial assistance.
This work was supported by Grants-in-Aid for Scientific Research
from the Ministry of Education, Science and Culture, and the Ministry
of Health, Labor and Welfare Japan.
Reprint requests to Takashi Saito, Ph.D., Department of Molecular
Genetics, Graduate School of Medicine, Chiba University, 1-8-1 Ino-
hana, Chuo-ku, Chiba 260-8670, Japan.
E-mail: saito@med.m.chiba-u.ac.jp
REFERENCES
1. Takai T, Li M, Sylvestre DL, et al: FcR gamma chain deletion
results in pleiotrophic effector cell defects. Cell 76:519–529, 1994
2. Clynes R, Ravetch JV: Cytotoxic antibodies trigger inflammation
through Fc receptors. Immunity 3:21–26, 1995
3. Hazenbos WL, Gessner JE, Hofhuis FM, et al: Impaired IgG-
dependent anaphylaxis and Arthus reaction in Fc gamma RIII
(CD16) deficient mice. Immunity 5:181–188, 1996
4. Sylvestre DL, Ravetch JV: A dominant role for mast cell Fc
receptors in the Arthus reaction. Immunity 5:387–390, 1996
5. Sylvestre DL, Clynes R, Ma M, et al: Immunoglobulin G-medi-
ated inflammatory responses develop normally in complement-
deficient mice. J Exp Med 184:2385–2392, 1996
6. Watanabe N, Akikusa B, Park SY, et al: Mast cells induce auto-
antibody-mediated vasculitis syndrome through tumor necrosis fac-
tor production upon triggering Fc gamma receptors. Blood 94:3855–
3863, 1999
7. Clynes R, Maizes JS, Guinamard R, et al: Modulation of immune
complex-induced inflammation in vivo by the coordinate expres-
sion of activation and inhibitory Fc receptors. J Exp Med 189:179–
185, 1999
8. Ravetch JV: Fc receptors: Rubor redux. Cell 78:553–560, 1994
9. Deo YM, Graziano RF, Repp R, et al: Clinical significance of IgG
Fc receptors and Fc gamma R-directed immunotherapies. Immunol
Today 18:127–135, 1997
10. Daeron M: Fc receptor biology. Annu Rev Immunol 15:203–234,
1997
11. Park SY, Ueda S, Ohno H, et al: Resistance of Fc receptor-
deficient mice to fatal glomerulonephritis. J Clin Invest 102:1229–
1238, 1998
12. Barnes N, Gavin AL, Tan PS, et al: Fc gamma RI-deficient mice
show multiple alterations to inflammatory and immune responses.
Immunity 16:379–389, 2002
13. Sylvestre DL, Ravetch JV: Fc receptors initiate the Arthus reac-
Fujii et al: FccR-induced glomerulonephritis1416
tion: Redefining the inflammatory cascade. Science 265:1095–1098,
1994
14. Meyer D, Schiller C, Westermann J, et al: Fc gamma RIII
(CD16)-deficient mice show IgG isotype-dependent protection to
experimental autoimmune hemolytic anemia. Blood 92:3997–4002,
1998
15. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, et al: Fc gamma RI
(CD64) contributes substantially to severity of arthritis, hypersensi-
tivity responses, and protection from bacterial infection. Immunity
16:391–402, 2002
16. Masugi M: Uber das Wesen der spezifischen Veraderungen der
Niere und der Leber durch das Nephrotoxin bzw das Hepatotoxin.
Zugleich ein Beitrag zur Pathogenese der Glomerulonephritis und
der eklamptischen Leber Erkrankung. Beitr Path Anat 91:82–112,
1933
17. Benoit FL, Rulon DB, Theil GB, et al: Goodpasture’s syndrome.
A clinicopathologic entity. Am J Med 37:424–444, 1964
18. Lerner RA, Glassock RJ, Dixon FJ: The role of anti-glomerular
basement membrane antibody in the pathogenesis of human glo-
merulonephritis. J Exp Med 126:989–1004, 1967
19. Couser WG, Darby C, Salant DJ, et al: Anti-GBM antibody-
induced proteinuria in isolated perfused rat kidney. Am J Physiol
249:F241–F250, 1985
20. Shigematsu H: Glomerular events during the initial phase of rat
Masugi nephritis. Virchows Arch B Cell Pathol 5:187–200, 1970
21. Schrijver G, Bogman MJ, Assmann KJ, et al: Anti-GBM nephritis
in the mouse: role of granulocytes in the heterologous phase. Kid-
ney Int 38:86–95, 1990
22. Suzuki Y, Shirato I, Okumura K, et al: Distinct contribution of
Fc receptors and angiotensin II-dependent pathways in anti-GBM
glomerulonephritis. Kidney Int 54:1166–1174, 1998
23. Coxon A, Cullere X, Knight S, et al: Fc gamma RIII mediates
neutrophil recruitment to immune complexes. A mechanism for
neutrophil accumulation in immune-mediated inflammation. Im-
munity 14:693–704, 2001
24. Raji L, Azar S, Keane W: Mesangial immuneinjury, hypertension,
and progressive glomerular damage in Dahl rats. Kidney Int 26:137–
143, 1984
25. Raji L, Dalmasso AP, Staley NA, et al: Renal injury in DOCA-
salt hypertensive C5-sufficient and C5-deficient mice. Kidney Int
36:582–592, 1989
26. Kanamaru Y, Nakao A, Mamura M, et al: Blockade of TGF-beta
signaling in T cell prevents the developement of experimental
glomerulonephritis. J Immunol 166:2818–2823, 2001
27. Ravetch JV, Kinet JP: Fc receptors. Annu Rev Immunol 9:457–
492, 1991
28. Gavin AL, Hamilton JA, Hogorth PM: Extracellular mutations
of non-obese diabetic mouse Fc gamma RI modify surface expres-
sion and ligand binding. J Biol Chem 271:17091–17099, 1996
29. Ji H, Ohmura K, Mahmood U, et al: Arthritis critically dependent
on innate immune system players. Immunity 16:157–168, 2002
30. Matsumoto I, Staub A, Benoist C, et al: Arthritis provoked by
linked T and B cell recognition of a glycolytic enzyme. Science
286:1732–1735, 1999
31. Stahl TD, Andren M, Martinsson P, et al: Expression of Fc
gamma RIII is required for development of collagen-induced ar-
thritis. Eur J Immunol 32:2915–2922, 2002
32. Van Lent PL, Nabbe K, Blom AB, et al: Role of activatory Fc
gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in
inflammation and cartilage destruction during experimental anti-
gen-induced arthritis. Am J Pathol 159:2309–2320, 2001
33. Baumann U, Chouchakova N, Gewecke B, et al: Distinct tissue
site-specific requirements of mast cells and complement compo-
nents C3/C5a receptor in IgG immune complex-induced injury of
skin and lung. J Immunol 167:1022–1027, 2001
34. Baumann U, Kohl J, Tschernig T, et al: A codominant role of
Fc gamma RI/III and C5aR in the reverse Arthus reaction. J
Immunol 164:1065–1070, 2000
35. Tarzi RM, Davies KA, Robson MG, et al: Nephrotoxic nephritis
is mediated by Fc gamma receptors on circulating leukocytes and
not intrinsic renal cells. Kidney Int 62:2087–2096, 2002
36. Assmann KJ, Tangelder MM, Lange WP, et al: Anti-GBM ne-
phritis in the mouse: severe proteinuria in the heterologous phase.
Virchows Arch A Pathol Anat Histopathol 406:285–299, 1985
37. Feith GW, Assmann KJ, Bogman MJ, et al: Lack of albuminuria
in the early heterologous phase of anti-GBM nephritis in beige
mice. Kidney Int 43:824–827, 1993
38. Schrijver G, Schalkwijk J, Robben JC, et al: Antiglomerular
basement membrane nephritis in beige mice. Deficiency of leuko-
cytic neutral proteinases prevents the induction of albuminuria in
the heterologous phase. J Exp Med 169:1435–1448, 1989
39. Tang T, Rosenkranz A, Assmann KJ, et al: A role for Mac-1
(CDIIb/CD18) in immune complex-stimulated neutrophil function
in vivo: Mac-1 deficiency abrogates sustained Fc gamma receptor-
dependent neutrophil adhesion and complement-dependent pro-
teinuria in acute glomerulonephritis. J Exp Med 186:1853–1863,
1997
40. Nikolic-Paterson DJ, Atkins RC: The role of macrophages in
glomerulonephritis. Nephrol Dial Transplant 16:3–7, 2001
41. Holdsworth SR, Neale TJ, Wilson CB: Abrogation of macro-
phage-dependent injury in experimental glomerulonephritis in the
rabbit. Use of an antimacrophage serum. J Clin Invest 68:686–698,
1981
42. Boyce NW, Holdsworth SR: Macrophage-Fc-receptor affinity:
role in cellular mediation of antibody initiated glomerulonephritis.
Kidney Int 36:537–544, 1989
43. Unkeless JC, Eisen HN: Binding of monomeric immunoglobulins
to Fc receptors of mouse macrophages. J Exp Med 142:1520–1533,
1975
44. Fossati-Jimack L, Ioan-Facsinay A, Reininger L, et al: Markedly
different pathogenicity of four immunoglobulin G isotype-switch
variants of an antierythrocyte autoantibody is based on their capac-
ity to interact in vivo with the low-affinity Fc gamma receptor III.
J Exp Med 191:1293–1302, 2000
45. Radeke HH, Gessner JE, Uciechowski P, et al: Intrinsic human
glomerular mesangial cells can express receptors for IgG com-
plexes (hFc gamma RIII-A) and the associated Fc epsilon RI
gamma-chain. J Immunol 153:1281–1292, 1994
46. Hora K, Satriano JA, Santriago A, et al: Receptors for IgG
complexes activate synthesis of monocyte chemoattractant peptide
1 and colony-stimulating factor 1. Proc Natl Acad Sci USA 89:1745–
1749, 1992
47. Gessner JE, Radeke HH, Uciechowski P, et al: Activation-depen-
dent expression of Fc gamma-receptors on glomerular mesangial
cells. Immun Infect 23:67–69, 1995
48. Radeke HH, Janssen-Graalfs I, Sowa EN, et al: Opposite regula-
tion of type II and III receptors for immunoglobulin G in mouse
glomerular mesangial cells and in the induction of anti-glomerular
basement membrane (GBM) nephritis. J Biol Chem 277:27535–
27544, 2002
